Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats

Vascular Pharmacology

Volumn 57, Issue 5-6, 2012, Pages 201-207

  Kumar, Binit ^a   Gupta, Suresh Kumar ^a   Srinivasan, B P ^a   Nag, Tapas Chandra ^b   Srivastava, Sushma ^a   Saxena, Rohit ^c  

^a UNIVERSITY OF DELHI   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Basement membrane; Fluorescein angiography; Hesperetin; Retinal leakage; Vasculopathy

Indexed keywords

HESPERETIN; PROTEIN KINASE C BETA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL PERMEABILITY; CAPILLARY BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; DRUG EFFECT; EYE FUNDUS; HYPERGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA FLUORESCEIN ANGIOGRAPHY; STREPTOZOCIN DIABETES; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR DISEASE;

ANGIOGENESIS INHIBITORS; ANIMALS; BASEMENT MEMBRANE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; FLUORESCEIN ANGIOGRAPHY; GENE EXPRESSION REGULATION; HESPERIDIN; HYPERGLYCEMIA; MICROSCOPY, ELECTRON, TRANSMISSION; PROTEIN KINASE C; RATS; RATS, WISTAR; RETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865636694     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.02.007     Document Type: Article

References (42)

1. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., Nguyen H.V., Aiello L.M., Ferrara N., King G.L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 1994, 331:1480-1487.
2. Aiello L.P., Pierce E.A., Foley E.D., Takagi H., Chen H., Riddle L., Ferrara N., King G.L., Smith L.E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:10457-10461.
3. Aiello L.P., Bursell S.E., Clermont A., Duh E., Ishii H., Takagi C., Mori F., Ciulla T.A., Ways K., Jirousek M., Smith L.E., King G.L. Vascular endothelial growth factor induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997, 46:1473-1480.
4. Ayo S.H., Radnik R., Garoni J.A., Troyer D.A., Kreisberg J.I. High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am. J. Physiol. 1991, 261:F571-F577.
5. Cho J. Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin. Arch. Pharm. Res. 2006, 29:699-706.
6. Choi E.J. Antioxidative effects of hesperetin against 7, 12-dimethylbenz(a)anthracene-induced oxidative stress in mice. Life Sci. 2008, 82:1059-1064.
7. Choi E.J., Ahn W.S. Neuroprotective effects of chronic hesperetin administration in mice. Arch. Pharm. Res. 2008, 31:1457-1462.
8. Choi E.J., Kim G.D., Chee K.M., Kim G.H. Effects of hesperetin on vessel structure formation in mouse embryonic stem (mES) cells. Nutrition 2006, 22:947-951.
9. Clarke M., Dodson P.M. PKC inhibition and diabetic microvascular complications. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21:573-586.
10. Donnelly R., Idris I., Forrester J.V. Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research. Br. J. Ophthalmol. 2004, 88:145-151.
11. Frank R.N. Diabetic Retinopathy. N. Engl. J. Med. 2004, 350:48-58.
12. Franke A.A., Cooney R.V., Henning S.M., Custer L.J. Bioavailability and antioxidant effects of orange juice components in humans. J. Agric. Food Chem. 2005, 53:5170-5178.
13. Fujiwara H., Hosokawa M., Zhou X., Fujimoto S., Fukuda K., Toyoda K., Nishi Y., Fujita Y., Yamada K., Yamada Y., Seino Y., Inagaki N. Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Res. Clin. Pract. 2008, 80:185-191.
14. Geraldes P., King G.L. Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications. Circ. Res. 2010, 106:1319-1331.
15. Geraldes P., Hiraoka-Yamamoto J., Matsumoto M., Clermont A., Leitges M., Marette A., Aiello L.P., Kern T.S., King G.L. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat. Med. 2009, 15:1298-1306.
16. Grant S., Tran P., Zhang Q., Zou A., Dinh D., Jensen J., Zhou S., Kang X., Zachwieja J., Lippincott J., Liu K., Johnson S.L., Scales S., Yin C., Nukui S., Stoner C., Prasanna G., Lafontaine J., Wells P., Li H. Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model. Eur. J. Pharmacol. 2010, 627:16-25.
17. Gupta S.K., Kumar B., Nag T.C., Agrawal S.S., Agrawal R., Agrawal P., Saxena R., Srivastava S. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J. Ocul. Pharmacol. Ther. 2011, 27:123-130.
18. Hardie D.G., Hawley S.A. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 2001, 23:1112-1119.
19. Hirata A., Murakami Y., Shoji M., Kadoma Y., Fujisawa S. Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression. Anticancer. Res. 2005, 25:3367-3374.
20. Hwang S.L., Yen G.C. Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. J. Agric. Food Chem. 2008, 56:859-864.
21. Kim J.H., Kim J.H., Jun H.O., Yu Y.S., Kim K.W. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy. Am. J. Pathol. 2010, 176:1517-1524.
22. Kim J.H., Kim J.H., Yu Y.S., Min B.H., Kim K.W. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2010, 51:1659-1665.
23. Kowalczuk L., Touchard E., Omri S., Jonet L., Klein C., Valamanes F., Berdugo M., Bigey P., Massin P., Jeanny J.C., Behar-Cohen F. Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. PLoS One 2011, 6:e17462.
24. Kuiper E.J., Hughes J.M., Van Geest R.J., Vogels I.M., Goldschmeding R., Van Noorden C.J., Schlingemann R.O., Klaassen I. Effect of VEGF-A on expression of profibrotic growth factor and extra-cellular matrix genes in the retina. Invest. Ophthalmol. Vis. Sci. 2007, 48:4267-4276.
25. Kumar B., Gupta S.K., Nag T.C., Srivastava S., Saxena R. Green Tea Prevents Hyperglycemia Induced Retinal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Rats. Ophthalmic Res. 2012, 47:103-108.
26. Lee M.S., Kim C.H., Hoang D.M., Kim B.Y., Sohn C.B., Kim M.R., Ahn J.S. Genistein-derivatives from Tetracera scandens stimulate glucose-uptake in L6 myotubes. Biol. Pharm. Bull. 2009, 32:504-508.
27. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 1951, 193:265-275.
28. Maharjan S., Lee S., Agrawal V., Choi H.J., Maeng Y.S., Kim K., Kim N.J., Suh Y.G., Kwon Y.G. Sac-0601 prevents retinal vascular leakage in a mouse model of diabetic retinopathy. Eur. J. Pharmacol. 2011, 657:35-40.
29. Majumdar S., Srirangam R. Solubility, Stability, Physicochemical Characteristics and In Vitro Ocular Tissue Permeability of Hesperidin: a Natural Bioflavonoid. Pharm. Res. 2009, 26:1217-1225.
30. Mojzis J., Varinska L., Mojzisova G., Kostova I., Mirossay L. Antiangiogenic effects of flavonoids and chalcones. Pharmacol. Res. 2008, 57:259-265.
31. Nicholson S.K., Tucker G.A., Brameld J.M. Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. Br. J. Nutr. 2010, 103:1398-1403.
32. Paysant J., Sansilvestri-Morel P., Bouskela E., Verbeuren T.J. Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation. Int. Angiol. 2008, 27:81-85.
33. Pfeiffer A., Schatz H. Diabetic microvascular complications and growth factors. Exp. clin. endocrinol. Diabetes 1995, 103:1759-1763.
34. Roy S., Sato T. Role of vascular basement membrane components in diabetic microangiopathy. Drug News Perspect. 2000, 13:91-98.
35. Roy S., Ha J., Trudeau K., Beglova E. Vascular basement membrane thickening in diabetic retinopathy. Curr. Eye Res. 2011, 35:1045-1056.
36. Srirangam R., Majumdar S. Passive asymmetric transport of hesperetin across isolated rabbit cornea. Int. J. Pharm. 2010, 394:60-67.
37. Stoclet J.C., Chataigneau T., Ndiaye M., Oak M.H., El Bedoui J., Chataigneau M., Schini-Kerth V.B. Vascular protection by dietary polyphenols. Eur. J. Pharmacol. 2004, 500:299-313.
38. Studer R.K., Craven P.A., DeRubertis F.R. Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 1993, 42:118-126.
39. Suzuma K., Takahara N., Suzuma I., Isshiki K., Ueki K., Leitges M., Aiello L.P., King G.L. Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation and retinal neovascularization. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:721-726.
40. Wang J., Xu X., Elliott M.H., Zhu M., Le Y.Z. Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 2010, 59:2297-22305.
41. Xia P., Aiello L.P., Ishii H., Jiang Z.Y., Park D.J., Robinson G.S., Takagi H., Newsome W.P., Jirousek M.R., King G.L. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms and endothelial cell growth. J. Clin. Invest. 1996, 98:2018-2026.
42. Zygmunt K., Faubert B., MacNeil J., Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochem. Biophys. Res. Commun. 2010, 398:178-183.